However, AML LSCs with high ALDH activity have also been described (Hoang et al., 2015; Ran et al., 2009; Blume et al., 2018), indicating that ALDH-based discrimination is variable across subtypes and lacks the specificity to serve as a standalone marker. The gene discussed is LDHA; the disease is acute myeloid leukemia.